Novartis : NVS

All Novartis Articles

134 Articles

Paul Ausick | Nov 7, 2012 at 2:49 PM EST

Ranking Innovation: Who’s Number 1?

courtesy of AppleIn its third annual ranking of the world’s most innovative companies, analysts at Booz & Co. created two…

Douglas A. McIntyre | Jul 19, 2012 at 6:15 AM EDT

Media Digest (7/19/2012) Reuters, WSJ, NYT, FT, Bloomberg

A new consumer agency fines Capital One (NYSE: COF) $210 million for aggressive marketing activity.(Reuters) New IMF policies will examine whether…

Douglas A. McIntyre | Mar 8, 2012 at 6:17 AM EST

Media Digest (3/8/2012) Reuters, WSJ, NYT, FT, Marketwatch

The CEO of Chrysler said he took no pay in 2011 and that, based on financial results, the company is…

Douglas A. McIntyre | Jan 13, 2012 at 6:43 AM EST

In Layoff Wave, a New Threat of Economic Retreat

The public and the press usually measure unemployment one month at a time as data from ADP and the federal…

Douglas A. McIntyre | Jan 13, 2012 at 6:40 AM EST

What’s Important in the Financial World (1/13/2012) iPhone Riots, Goldman Oil Price Forecast

Layoffs have surged recently. There is no telling why they happened all at about the same time. Drug giant Novartis (NYSE:…

Douglas A. McIntyre | Jan 13, 2012 at 6:39 AM EST

Media Digest (1/13/2012) Reuters, WSJ, NYT, FT, Bloomberg

TPG may invest $1 billion in troubled Olympus. (Reuters) President Obama to ask for a $1.2 trillion increase in the…

Paul Ausick | Jan 9, 2012 at 7:37 AM EST

Novartis Recalls Excedrin, Other Over-the-Counter Meds (NVS)

Drug maker Novartis AG (NYSE: NVS) has issued a recall notice for several of its popular over-the-counter medicines: Novartis Consumer…

Douglas A. McIntyre | Dec 13, 2011 at 6:35 AM EST

Media Digest (12/13/2011) Reuters, WSJ, NYTimes, Bloomberg

Congress, close to a budget agreement, may avoid a government shutdown. (Reuters) Washington Mutual shareholders and creditors set a deal…

Douglas A. McIntyre | Dec 8, 2011 at 6:23 AM EST

Media Digest (12/8/2011) Reuters, WSJ, NYTimes, FT, Bloomberg

S&P may downgrade the EU and the largest eurozone banks. (Reuters) France and Germany continue to press new eurozone treaty measures…

Douglas A. McIntyre | Oct 25, 2011 at 6:24 AM EDT

Novartis Cuts 2,000 as Pharma Industry Continues to Falter

Novartis (NYSE: NVS) said it would cut 2,000 workers and outsource some functions to companies that will do the work…

Douglas A. McIntyre | Oct 25, 2011 at 6:16 AM EDT

Media Digest (10/25/2011) Reuters, WSJ, NYTimes, FT, Bloomberg

The Obama administration announces a new plan to help underwater mortgage holders. (Reuters) Netflix (NASDAQ: NFLX) warns that more subscribers…

Douglas A. McIntyre | Oct 24, 2011 at 6:33 AM EDT

R&D Spenders Get No Respect

A company can spend billions of dollars on R&D and get little respect as an innovator. Even though that is…

Douglas A. McIntyre | Jul 19, 2011 at 9:58 AM EDT

The 24/7 Wall St./Flame Index: The Companies With The Most Bad Press (7/19)

Earnings dominated the press coverage of today’s shares. Novartis and Harley-Davidson released numbers Icahn Enterprise was thumped after it made…

Douglas A. McIntyre | Jul 18, 2011 at 8:02 PM EDT

The Eleven Most Implanted Medical Devices In America

Implanted medical devices are one of the most profitable businesses of the U.S. healthcare industry. While many devices help extend…

Douglas A. McIntyre | Jul 6, 2011 at 9:37 AM EDT

The 24/7 Wall St./Flame Index: Companies With The Worst News (July 7)

Nothing compared to the negative press News Corp (NYSE: NWS) has gotten in the last three days as its The…

1 … 5 6 7 8 9

Novartis : NVS

All Novartis Articles

Ranking Innovation: Who’s Number 1?

Media Digest (7/19/2012) Reuters, WSJ, NYT, FT, Bloomberg

Media Digest (3/8/2012) Reuters, WSJ, NYT, FT, Marketwatch

In Layoff Wave, a New Threat of Economic Retreat

What’s Important in the Financial World (1/13/2012) iPhone Riots, Goldman Oil Price Forecast

Media Digest (1/13/2012) Reuters, WSJ, NYT, FT, Bloomberg

Novartis Recalls Excedrin, Other Over-the-Counter Meds (NVS)

Media Digest (12/13/2011) Reuters, WSJ, NYTimes, Bloomberg

Media Digest (12/8/2011) Reuters, WSJ, NYTimes, FT, Bloomberg

Novartis Cuts 2,000 as Pharma Industry Continues to Falter

Media Digest (10/25/2011) Reuters, WSJ, NYTimes, FT, Bloomberg

R&D Spenders Get No Respect

The 24/7 Wall St./Flame Index: The Companies With The Most Bad Press (7/19)

The Eleven Most Implanted Medical Devices In America

The 24/7 Wall St./Flame Index: Companies With The Worst News (July 7)

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

Novartis : NVS

All Novartis Articles

Ranking Innovation: Who’s Number 1?

Media Digest (7/19/2012) Reuters, WSJ, NYT, FT, Bloomberg

Media Digest (3/8/2012) Reuters, WSJ, NYT, FT, Marketwatch

In Layoff Wave, a New Threat of Economic Retreat

What’s Important in the Financial World (1/13/2012) iPhone Riots, Goldman Oil Price Forecast

Media Digest (1/13/2012) Reuters, WSJ, NYT, FT, Bloomberg

Novartis Recalls Excedrin, Other Over-the-Counter Meds (NVS)

Media Digest (12/13/2011) Reuters, WSJ, NYTimes, Bloomberg

Media Digest (12/8/2011) Reuters, WSJ, NYTimes, FT, Bloomberg

Novartis Cuts 2,000 as Pharma Industry Continues to Falter

Media Digest (10/25/2011) Reuters, WSJ, NYTimes, FT, Bloomberg

R&D Spenders Get No Respect

The 24/7 Wall St./Flame Index: The Companies With The Most Bad Press (7/19)

The Eleven Most Implanted Medical Devices In America

The 24/7 Wall St./Flame Index: Companies With The Worst News (July 7)

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

Featured Reads

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not